150 related articles for article (PubMed ID: 18297140)
21. [Antidiabetic Drugs and the Kidney].
Candido R
G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960013
[No Abstract] [Full Text] [Related]
22. Pharmacological treatment of type 2 diabetes.
Hermans MP; Buysschaert M
Acta Clin Belg; 2004; 59(2):59-66. PubMed ID: 15224468
[No Abstract] [Full Text] [Related]
23. The impact of diabetes and diabetes medications on bone health.
Gilbert MP; Pratley RE
Endocr Rev; 2015 Apr; 36(2):194-213. PubMed ID: 25738213
[TBL] [Abstract][Full Text] [Related]
24. [Long term efficacy and tolerance of antidiabetic treatments. New data].
Mirouze J
Nouv Presse Med; 1974 Jun; 3(24):1551-4. PubMed ID: 4211493
[No Abstract] [Full Text] [Related]
25. Are you up-to-date on diabetes medications?
Scemons D
Nursing; 2007 Jul; 37(7):45-9; quiz 49-50. PubMed ID: 17603373
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS
Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
[TBL] [Abstract][Full Text] [Related]
27. Novel pharmacologic agents for type 2 diabetes.
Uwaifo GI; Ratner RE
Endocrinol Metab Clin North Am; 2005 Mar; 34(1):155-97. PubMed ID: 15752927
[TBL] [Abstract][Full Text] [Related]
28. Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm.
Bailey T
Am J Med; 2013 Sep; 126(9 Suppl 1):S10-20. PubMed ID: 23953074
[TBL] [Abstract][Full Text] [Related]
29. Diabetes under control: Understanding oral antidiabetic agents.
Longo R
Am J Nurs; 2010 Feb; 110(2):49-52. PubMed ID: 20107402
[No Abstract] [Full Text] [Related]
30. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
Inzucchi SE
Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
[No Abstract] [Full Text] [Related]
31. Evolving therapeutic options for type 2 diabetes mellitus: an overview.
Guthrie RM
Postgrad Med; 2012 Nov; 124(6):82-9. PubMed ID: 23322141
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease.
Scheen AJ
Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):839-57. PubMed ID: 24669954
[TBL] [Abstract][Full Text] [Related]
33. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.
Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Shiraki K; Hayakawa M; Shibasaki M
Metabolism; 2009 Mar; 58(3):379-86. PubMed ID: 19217455
[TBL] [Abstract][Full Text] [Related]
34. A report from the 46th Annual Meeting of the European Association for the Study of Diabetes (September 20-24, 2010 - Stockholm, Sweden).
Rabasseda X
Drugs Today (Barc); 2011 Jan; 47(1):77-95. PubMed ID: 21373651
[TBL] [Abstract][Full Text] [Related]
35. Alternative Agents in Type 1 Diabetes in Addition to Insulin Therapy: Metformin, Alpha-Glucosidase Inhibitors, Pioglitazone, GLP-1 Agonists, DPP-IV Inhibitors, and SGLT-2 Inhibitors.
DeGeeter M; Williamson B
J Pharm Pract; 2016 Apr; 29(2):144-59. PubMed ID: 25312263
[TBL] [Abstract][Full Text] [Related]
36. Time trends and regional variation in utilization of antidiabetic medicines in China, 2015-2022.
Zhang J; Xu S; Liu X; Zhang J; Hu S; Liu X; Yang C; Fang Y
Diabetes Obes Metab; 2024 Jul; 26(7):2752-2760. PubMed ID: 38618979
[TBL] [Abstract][Full Text] [Related]
37. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
38. Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: for GLP-1/DPP-IV inhibitors.
Kumar A
Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():21-5. PubMed ID: 23280862
[TBL] [Abstract][Full Text] [Related]
39. Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes.
Chaudhuri A; Dandona P
Diabetes Obes Metab; 2011 Oct; 13(10):869-79. PubMed ID: 21569185
[TBL] [Abstract][Full Text] [Related]
40. Comparative adherence to diabetes drugs: An analysis of electronic health records and claims data.
Flory J; Gerhard T; Stempniewicz N; Keating S; Rowan CG
Diabetes Obes Metab; 2017 Aug; 19(8):1184-1187. PubMed ID: 28266807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
